XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities    
Net loss $ (4,542,163) $ (778,427)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 277,856 320,667
Credit loss (recovery) expense 3,970 (48,908)
Gain on debt settlement 0 (579,977)
Equity based compensation expense 2,215,205 299,847
Change in fair value of warrant liability 7,585 (64,096)
Change in fair value of contingent consideration (164,384) 0
Change in fair value of derivative liability (113,333) 0
(Gain) or loss on change in fair value of marketable securities (1,809) 108,512
Gain on assets sale 0 (100,000)
Amortization of debt discount and debt costs 0 177,072
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable (1,283,124) 392,193
Increase in prepaid expenses and other current assets 379,121 29,950
Increase (decrease) in accounts payable and accrued liabilities 1,381,118 (399,272)
(Decrease) increase in deferred revenue 1,134 (27,359)
Net cash (used) in operating activities (1,838,824) (669,798)
Cash Flows From Investing Activities:    
Purchase of intangible assets (400,000) 0
Proceeds from sale of assets 0 100,000
Net cash (used) in provided by investing activities (400,000) 100,000
Cash Flows From Financing Activities:    
Payments of promissory notes 0 (592,057)
Repayments of notes 0 (129,000)
Gross proceeds from exercise of warrants 0 592,057
Net cash used in financing activities 0 (129,000)
Net decrease in cash (2,238,824) (698,798)
Cash, beginning of period 2,532,990 1,008,408
Cash, end of period 294,166 309,610
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 0 53,941
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Issuance of common stock upon purchase of intangible assets 5,311,508 647,055
Contingent consideration recorded as intangible asset 605,004 0
Issuance of common stock issued upon conversion of promissory notes 0 523,380
Warrants issued in connection with purchase of intangible assets 0 480,358
Issuance of common stock issued upon conversion of note payable 0 273,673
Issuance of common stock from conversion of Preferred stock, Series E $ 0 $ 9